Evidence-Based Complementary and Alternative Medicine 11 [51] M. S. Hong, H. K. Park, J. S. Yang et al., “Gene expression proﬁle of acupuncture treatment in 1-methyl-4-phenyl-1,2, 3,6- tetrahydropyridine-induced Parkinson’s disease model,” Neurological Research, vol. 32, Supplement 1, pp. S74–S78, 2010. [52] M. A. Noureddine, Y. J. Li, J. M. van der Walt et al., “Genomic convergence to identify candidate genes for Parkinson’s disease: SAGE analysis of the substantia nigra,” Movement Disorders, vol. 20, no. 10, pp. 1299–1309, 2005. [53] C. K. Kim, G. S. Choi, S. D. Oh et al., “Electroacupuncture up-regulates natural killer cell activity: identiﬁcation of genes altering their expressions in electroacupuncture induced up- regulation of natural killer cell activity,” Journal of Neuroim- munology, vol. 168, no. 1-2, pp. 144–153, 2005. [54] S. K. Kim, J. Kim, E. Ko et al., “Gene expression proﬁle of the hypothalamus in DNP-KLH immunized mice following electroacupuncture stimulation,” Evidence-Based Comple- mentary and Alternative Medicine, vol. 2011, Article ID 508689, 8 pages, 2011. [55] S. H. Sohn, S. K. Kim, E. Ko et al., “The genome- wide expression proﬁle of electroacupuncture in DNP-KLH immunized mice,” Cellular and Molecular Neurobiology, vol. 30, no. 4, pp. 631–640, 2010. [56] H. S. Shiue, Y. S. Lee, C. N. Tsai, Y. M. Hsueh, J. R. Sheu, and H. H. Chang, “DNA microarray analysis of the eﬀect on inﬂammation in patients treated with acupuncture for allergic rhinitis,” Journal of Alternative and Complementary Medicine, vol. 14, no. 6, pp. 689–698, 2008. [57] H. S. Shiue, Y. S. Lee, C. N. Tsai, Y. M. Hsueh, J. R. Sheu, and H. H. Chang, “Gene expression proﬁle of patients with phadiatop-positive and -negative allergic rhinitis treated with acupuncture,” Journal of Alternative and Complementary Medicine, vol. 16, no. 1, pp. 59–68, 2010. [58] I. M. Cojocaru, M. Cojocaru, R. Taˇnaˇsescu et al., “Changes in plasma levels of complement in patients with acute ischemic stroke,” Romanian Journal of Internal Medicine, vol. 46, no. 1, pp. 77–80, 2008. [59] W. J. Li, S. Q. Pan, Y. S. Zeng et al., “Identiﬁcation of acupuncture-speciﬁc proteins in the process of electro- acupuncture after spinal cord injury,” Neuroscience Research, vol. 67, no. 4, pp. 307–316, 2010. [60] C. P. M. Reutelingsperger and W. L. Van Heerde, “Annexin V, the regulator of phosphatidylserine-catalyzed inﬂammation and coagulation during apoptosis,” Cellular and Molecular Life Sciences, vol. 53, no. 6, pp. 527–532, 1997. [61] L. H. Wang and S. M. Strittmatter, “A family of rat CRMP genes is diﬀerentially expressed in the nervous system,” Journal of Neuroscience, vol. 16, no. 19, pp. 6197–6207, 1996. [62] J. R. Siebert, F. A. Middleton, and D. J. Stelzner, “Long descending cervical propriospinal neurons diﬀer from tho- racic propriospinal neurons in response to low thoracic spinal injury,” BMC Neuroscience, vol. 11, article 148, 2010. [63] S. Jeon, J. K. Youn, S. T. Kim et al., “Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson’s disease mouse model,” Proteomics, vol. 8, no. 22, pp. 4822–4832, 2008. [64] S. T. Kim, W. Moon, Y. Chae, Y. J. Kim, H. Lee, and H. J. Park, “The eﬀect of electroaucpuncture for 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine-induced proteomic changes in the mouse striatum,” Journal of Physiological Sciences, vol. 60, no. 1, pp. 27–34, 2010. [65] D. Sliva, “Cellular and physiological eﬀects of Ganoderma lucidum (Reishi),” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 8, pp. 873–879, 2004. [66] C. Y. Lai, J. T. Hung, H. H. Lin et al., “Immunomodulatory and adjuvant activities of a polysaccharide extract of Gano- derma lucidum in vivo and in vitro,” Vaccine, vol. 28, no. 31, pp. 4945–4954, 2010. [67] Y. L. Lin, S. S. Lee, S. M. Hou, and B. L. Chiang, “Polysac- charide puriﬁed from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice,” Molecular Pharmacology, vol. 70, no. 2, pp. 637–644, 2006. [68] H. R. Lemmon, J. Sham, L. A. Chau, and J. Madrenas, “High molecular weight polysaccharides are key immunomodula- tors in North American ginseng extracts: characterization of the ginseng genetic signature in primary human immune cells,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 1– 13, 2012. [69] C. H. Cheng, A. Y. Leung, and C. F. Chen, “The eﬀects of two diﬀerent ganoderma species (Lingzhi) on gene expression in human monocytic THP-1 cells,” Nutrition and Cancer, vol. 62, no. 5, pp. 648–658, 2010. [70] J. Wu, M. Zhang, H. Jia et al., “Protosappanin A induces immunosuppression of rats heart transplantation targeting T cells in grafts via NF-κB pathway,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 381, no. 1, pp. 83–92, 2010. [71] K. C. Cheng, H. C. Huang, J. H. Chen et al., “Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction,” BMC Genomics, vol. 8, article 411, 2007. [72] Q. Zhang, F. Wei, C. C. Fong et al., “Transcriptional proﬁling of human skin ﬁbroblast cell line Hs27 induced by herbal formula Astragali Radix and Rehmanniae Radix,” Journal of Ethnopharmacology, vol. 138, no. 3, pp. 668–675, 2011. [73] H. Zhao, J. Deneau, G. O. Che et al., “Angelica sinensis isolate SBD. 4: composition, gene expression proﬁling, mechanism of action and eﬀect on wounds, in rats and humans,” Euro- pean Journal of Dermatology, vol. 22, no. 1, pp. 58–67, 2012. [74] Y. Sun, S. M. Y. Lee, Y. M. Wong et al., “Dosing eﬀects of an antiosteoporosis herbal formula—a preclinical investigation using a rat model,” Phytotherapy Research, vol. 22, no. 2, pp. 267–273, 2008. [75] X. Luo, C. Z. Wang, J. Chen et al., “Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells,” International Journal of Oncology, vol. 32, no. 5, pp. 975–983, 2008. [76] M. L. King and L. L. Murphy, “American ginseng (Panax Quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7- cells,” Journal of Experimental Therapeutics and Oncology, vol. 6, no. 2, pp. 147–155, 2007. [77] A. Hara, N. Iizuka, Y. Hamamoto et al., “Molecular dissection of a medicinal herb with anti-tumor activity by oligonu- cleotide microarray,” Life Sciences, vol. 77, no. 9, pp. 991– 1002, 2005. [78] N. Iizuka, M. Oka, K. Yamamoto et al., “Identiﬁcation of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray,” International Journal of Cancer, vol. 107, no. 4, pp. 666–672, 2003. [79] H. Wang, Y. Ye, S. Y. Pan et al., “Proteomic identiﬁcation of proteins involved in the anticancer activities of oridonin in HepG2 cells,” Phytomedicine, vol. 18, no. 2-3, pp. 163–169, 2011. [80] Y. Xu, J. F. Chiu, Q. Y. He, and F. Chen, “Tubeimoside- 1 exerts cytotoxicity in heLa cells Through mitochondrial dysfunction and endoplasmic reticulum stress pathways,”